Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Human Vaccines market report explains the definition, types, applications, major countries, and major players of the Human Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Zhongyianke Biotech
ChengDa Bio
GSK
Tiantan biological
Rong An
SINOVAC BIOTECH
CNBG
Kangtai
Hissen
Adimmune
NuoCheng Bio
Walvax Biotechnology
Zhifei
Changsheng Life
Changchun Baike
Hualan Bio
SANOFI
By Type:
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Other
By End-User:
Adults
Children
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Human Vaccines Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Human Vaccines Outlook to 2028- Original Forecasts
-
2.2 Human Vaccines Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Human Vaccines Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Human Vaccines Market- Recent Developments
-
6.1 Human Vaccines Market News and Developments
-
6.2 Human Vaccines Market Deals Landscape
7 Human Vaccines Raw Materials and Cost Structure Analysis
-
7.1 Human Vaccines Key Raw Materials
-
7.2 Human Vaccines Price Trend of Key Raw Materials
-
7.3 Human Vaccines Key Suppliers of Raw Materials
-
7.4 Human Vaccines Market Concentration Rate of Raw Materials
-
7.5 Human Vaccines Cost Structure Analysis
-
7.5.1 Human Vaccines Raw Materials Analysis
-
7.5.2 Human Vaccines Labor Cost Analysis
-
7.5.3 Human Vaccines Manufacturing Expenses Analysis
8 Global Human Vaccines Import and Export Analysis (Top 10 Countries)
-
8.1 Global Human Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Human Vaccines Export by Region (Top 10 Countries) (2017-2028)
9 Global Human Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global Human Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Varicella Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Influenza Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Polio Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Hepatitis A Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Rabies Consumption and Growth Rate (2017-2022)
-
9.1.6 Global BCG Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Hepatitis B Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Adults Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Children Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Human Vaccines Market Analysis and Outlook till 2022
-
10.1 Global Human Vaccines Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Human Vaccines Consumption (2017-2022)
-
10.2.2 Canada Human Vaccines Consumption (2017-2022)
-
10.2.3 Mexico Human Vaccines Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Human Vaccines Consumption (2017-2022)
-
10.3.2 UK Human Vaccines Consumption (2017-2022)
-
10.3.3 Spain Human Vaccines Consumption (2017-2022)
-
10.3.4 Belgium Human Vaccines Consumption (2017-2022)
-
10.3.5 France Human Vaccines Consumption (2017-2022)
-
10.3.6 Italy Human Vaccines Consumption (2017-2022)
-
10.3.7 Denmark Human Vaccines Consumption (2017-2022)
-
10.3.8 Finland Human Vaccines Consumption (2017-2022)
-
10.3.9 Norway Human Vaccines Consumption (2017-2022)
-
10.3.10 Sweden Human Vaccines Consumption (2017-2022)
-
10.3.11 Poland Human Vaccines Consumption (2017-2022)
-
10.3.12 Russia Human Vaccines Consumption (2017-2022)
-
10.3.13 Turkey Human Vaccines Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Human Vaccines Consumption (2017-2022)
-
10.4.2 Japan Human Vaccines Consumption (2017-2022)
-
10.4.3 India Human Vaccines Consumption (2017-2022)
-
10.4.4 South Korea Human Vaccines Consumption (2017-2022)
-
10.4.5 Pakistan Human Vaccines Consumption (2017-2022)
-
10.4.6 Bangladesh Human Vaccines Consumption (2017-2022)
-
10.4.7 Indonesia Human Vaccines Consumption (2017-2022)
-
10.4.8 Thailand Human Vaccines Consumption (2017-2022)
-
10.4.9 Singapore Human Vaccines Consumption (2017-2022)
-
10.4.10 Malaysia Human Vaccines Consumption (2017-2022)
-
10.4.11 Philippines Human Vaccines Consumption (2017-2022)
-
10.4.12 Vietnam Human Vaccines Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Human Vaccines Consumption (2017-2022)
-
10.5.2 Colombia Human Vaccines Consumption (2017-2022)
-
10.5.3 Chile Human Vaccines Consumption (2017-2022)
-
10.5.4 Argentina Human Vaccines Consumption (2017-2022)
-
10.5.5 Venezuela Human Vaccines Consumption (2017-2022)
-
10.5.6 Peru Human Vaccines Consumption (2017-2022)
-
10.5.7 Puerto Rico Human Vaccines Consumption (2017-2022)
-
10.5.8 Ecuador Human Vaccines Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Human Vaccines Consumption (2017-2022)
-
10.6.2 Kuwait Human Vaccines Consumption (2017-2022)
-
10.6.3 Oman Human Vaccines Consumption (2017-2022)
-
10.6.4 Qatar Human Vaccines Consumption (2017-2022)
-
10.6.5 Saudi Arabia Human Vaccines Consumption (2017-2022)
-
10.6.6 United Arab Emirates Human Vaccines Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Human Vaccines Consumption (2017-2022)
-
10.7.2 South Africa Human Vaccines Consumption (2017-2022)
-
10.7.3 Egypt Human Vaccines Consumption (2017-2022)
-
10.7.4 Algeria Human Vaccines Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Human Vaccines Consumption (2017-2022)
-
10.8.2 New Zealand Human Vaccines Consumption (2017-2022)
11 Global Human Vaccines Competitive Analysis
-
11.1 Zhongyianke Biotech
-
11.1.1 Zhongyianke Biotech Company Details
-
11.1.2 Zhongyianke Biotech Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Zhongyianke Biotech Human Vaccines Main Business and Markets Served
-
11.1.4 Zhongyianke Biotech Human Vaccines Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 ChengDa Bio
-
11.2.1 ChengDa Bio Company Details
-
11.2.2 ChengDa Bio Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 ChengDa Bio Human Vaccines Main Business and Markets Served
-
11.2.4 ChengDa Bio Human Vaccines Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 GSK
-
11.3.1 GSK Company Details
-
11.3.2 GSK Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 GSK Human Vaccines Main Business and Markets Served
-
11.3.4 GSK Human Vaccines Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Tiantan biological
-
11.4.1 Tiantan biological Company Details
-
11.4.2 Tiantan biological Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Tiantan biological Human Vaccines Main Business and Markets Served
-
11.4.4 Tiantan biological Human Vaccines Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Rong An
-
11.5.1 Rong An Company Details
-
11.5.2 Rong An Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Rong An Human Vaccines Main Business and Markets Served
-
11.5.4 Rong An Human Vaccines Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 SINOVAC BIOTECH
-
11.6.1 SINOVAC BIOTECH Company Details
-
11.6.2 SINOVAC BIOTECH Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 SINOVAC BIOTECH Human Vaccines Main Business and Markets Served
-
11.6.4 SINOVAC BIOTECH Human Vaccines Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 CNBG
-
11.7.1 CNBG Company Details
-
11.7.2 CNBG Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 CNBG Human Vaccines Main Business and Markets Served
-
11.7.4 CNBG Human Vaccines Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Kangtai
-
11.8.1 Kangtai Company Details
-
11.8.2 Kangtai Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Kangtai Human Vaccines Main Business and Markets Served
-
11.8.4 Kangtai Human Vaccines Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Hissen
-
11.9.1 Hissen Company Details
-
11.9.2 Hissen Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Hissen Human Vaccines Main Business and Markets Served
-
11.9.4 Hissen Human Vaccines Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Adimmune
-
11.10.1 Adimmune Company Details
-
11.10.2 Adimmune Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Adimmune Human Vaccines Main Business and Markets Served
-
11.10.4 Adimmune Human Vaccines Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 NuoCheng Bio
-
11.11.1 NuoCheng Bio Company Details
-
11.11.2 NuoCheng Bio Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 NuoCheng Bio Human Vaccines Main Business and Markets Served
-
11.11.4 NuoCheng Bio Human Vaccines Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Walvax Biotechnology
-
11.12.1 Walvax Biotechnology Company Details
-
11.12.2 Walvax Biotechnology Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Walvax Biotechnology Human Vaccines Main Business and Markets Served
-
11.12.4 Walvax Biotechnology Human Vaccines Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Zhifei
-
11.13.1 Zhifei Company Details
-
11.13.2 Zhifei Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Zhifei Human Vaccines Main Business and Markets Served
-
11.13.4 Zhifei Human Vaccines Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Changsheng Life
-
11.14.1 Changsheng Life Company Details
-
11.14.2 Changsheng Life Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Changsheng Life Human Vaccines Main Business and Markets Served
-
11.14.4 Changsheng Life Human Vaccines Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Changchun Baike
-
11.15.1 Changchun Baike Company Details
-
11.15.2 Changchun Baike Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Changchun Baike Human Vaccines Main Business and Markets Served
-
11.15.4 Changchun Baike Human Vaccines Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Hualan Bio
-
11.16.1 Hualan Bio Company Details
-
11.16.2 Hualan Bio Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Hualan Bio Human Vaccines Main Business and Markets Served
-
11.16.4 Hualan Bio Human Vaccines Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 SANOFI
-
11.17.1 SANOFI Company Details
-
11.17.2 SANOFI Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 SANOFI Human Vaccines Main Business and Markets Served
-
11.17.4 SANOFI Human Vaccines Product Portfolio
-
11.17.5 Recent Research and Development Strategies
12 Global Human Vaccines Market Outlook by Types and Applications to 2028
-
12.1 Global Human Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Varicella Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Influenza Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Polio Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Hepatitis A Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Rabies Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global BCG Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)
-
12.1.8 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Human Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Children Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Human Vaccines Market Analysis and Outlook to 2028
-
13.1 Global Human Vaccines Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Human Vaccines Consumption Forecast (2022-2028)
-
13.2.2 Canada Human Vaccines Consumption Forecast (2022-2028)
-
13.2.3 Mexico Human Vaccines Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Human Vaccines Consumption Forecast (2022-2028)
-
13.3.2 UK Human Vaccines Consumption Forecast (2022-2028)
-
13.3.3 Spain Human Vaccines Consumption Forecast (2022-2028)
-
13.3.4 Belgium Human Vaccines Consumption Forecast (2022-2028)
-
13.3.5 France Human Vaccines Consumption Forecast (2022-2028)
-
13.3.6 Italy Human Vaccines Consumption Forecast (2022-2028)
-
13.3.7 Denmark Human Vaccines Consumption Forecast (2022-2028)
-
13.3.8 Finland Human Vaccines Consumption Forecast (2022-2028)
-
13.3.9 Norway Human Vaccines Consumption Forecast (2022-2028)
-
13.3.10 Sweden Human Vaccines Consumption Forecast (2022-2028)
-
13.3.11 Poland Human Vaccines Consumption Forecast (2022-2028)
-
13.3.12 Russia Human Vaccines Consumption Forecast (2022-2028)
-
13.3.13 Turkey Human Vaccines Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Human Vaccines Consumption Forecast (2022-2028)
-
13.4.2 Japan Human Vaccines Consumption Forecast (2022-2028)
-
13.4.3 India Human Vaccines Consumption Forecast (2022-2028)
-
13.4.4 South Korea Human Vaccines Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Human Vaccines Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Human Vaccines Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Human Vaccines Consumption Forecast (2022-2028)
-
13.4.8 Thailand Human Vaccines Consumption Forecast (2022-2028)
-
13.4.9 Singapore Human Vaccines Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Human Vaccines Consumption Forecast (2022-2028)
-
13.4.11 Philippines Human Vaccines Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Human Vaccines Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Human Vaccines Consumption Forecast (2022-2028)
-
13.5.2 Colombia Human Vaccines Consumption Forecast (2022-2028)
-
13.5.3 Chile Human Vaccines Consumption Forecast (2022-2028)
-
13.5.4 Argentina Human Vaccines Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Human Vaccines Consumption Forecast (2022-2028)
-
13.5.6 Peru Human Vaccines Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Human Vaccines Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Human Vaccines Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Human Vaccines Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Human Vaccines Consumption Forecast (2022-2028)
-
13.6.3 Oman Human Vaccines Consumption Forecast (2022-2028)
-
13.6.4 Qatar Human Vaccines Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Human Vaccines Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Human Vaccines Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Human Vaccines Consumption Forecast (2022-2028)
-
13.7.2 South Africa Human Vaccines Consumption Forecast (2022-2028)
-
13.7.3 Egypt Human Vaccines Consumption Forecast (2022-2028)
-
13.7.4 Algeria Human Vaccines Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Human Vaccines Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Human Vaccines Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Human Vaccines
-
Figure of Human Vaccines Picture
-
Table Global Human Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Human Vaccines Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Varicella Consumption and Growth Rate (2017-2022)
-
Figure Global Influenza Consumption and Growth Rate (2017-2022)
-
Figure Global Polio Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis A Consumption and Growth Rate (2017-2022)
-
Figure Global Rabies Consumption and Growth Rate (2017-2022)
-
Figure Global BCG Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis B Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Adults Consumption and Growth Rate (2017-2022)
-
Figure Global Children Consumption and Growth Rate (2017-2022)
-
Figure Global Human Vaccines Consumption by Country (2017-2022)
-
Table North America Human Vaccines Consumption by Country (2017-2022)
-
Figure United States Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Canada Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Mexico Human Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe Human Vaccines Consumption by Country (2017-2022)
-
Figure Germany Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure UK Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Spain Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Belgium Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure France Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Italy Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Denmark Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Finland Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Norway Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Sweden Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Poland Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Russia Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Turkey Human Vaccines Consumption and Growth Rate (2017-2022)
-
Table APAC Human Vaccines Consumption by Country (2017-2022)
-
Figure China Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Thailand Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Singapore Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Philippines Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Human Vaccines Consumption and Growth Rate (2017-2022)
-
Table South America Human Vaccines Consumption by Country (2017-2022)
-
Figure Brazil Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Colombia Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Chile Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Argentina Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Peru Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Human Vaccines Consumption and Growth Rate (2017-2022)
-
Table GCC Human Vaccines Consumption by Country (2017-2022)
-
Figure Bahrain Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Oman Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Qatar Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Human Vaccines Consumption and Growth Rate (2017-2022)
-
Table Africa Human Vaccines Consumption by Country (2017-2022)
-
Figure Nigeria Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Africa Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Egypt Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Algeria Human Vaccines Consumption and Growth Rate (2017-2022)
-
Table Oceania Human Vaccines Consumption by Country (2017-2022)
-
Figure Australia Human Vaccines Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Human Vaccines Consumption and Growth Rate (2017-2022)
-
Table Zhongyianke Biotech Company Details
-
Table Zhongyianke Biotech Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zhongyianke Biotech Human Vaccines Main Business and Markets Served
-
Table Zhongyianke Biotech Human Vaccines Product Portfolio
-
Table ChengDa Bio Company Details
-
Table ChengDa Bio Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table ChengDa Bio Human Vaccines Main Business and Markets Served
-
Table ChengDa Bio Human Vaccines Product Portfolio
-
Table GSK Company Details
-
Table GSK Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Human Vaccines Main Business and Markets Served
-
Table GSK Human Vaccines Product Portfolio
-
Table Tiantan biological Company Details
-
Table Tiantan biological Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tiantan biological Human Vaccines Main Business and Markets Served
-
Table Tiantan biological Human Vaccines Product Portfolio
-
Table Rong An Company Details
-
Table Rong An Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rong An Human Vaccines Main Business and Markets Served
-
Table Rong An Human Vaccines Product Portfolio
-
Table SINOVAC BIOTECH Company Details
-
Table SINOVAC BIOTECH Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table SINOVAC BIOTECH Human Vaccines Main Business and Markets Served
-
Table SINOVAC BIOTECH Human Vaccines Product Portfolio
-
Table CNBG Company Details
-
Table CNBG Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table CNBG Human Vaccines Main Business and Markets Served
-
Table CNBG Human Vaccines Product Portfolio
-
Table Kangtai Company Details
-
Table Kangtai Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kangtai Human Vaccines Main Business and Markets Served
-
Table Kangtai Human Vaccines Product Portfolio
-
Table Hissen Company Details
-
Table Hissen Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hissen Human Vaccines Main Business and Markets Served
-
Table Hissen Human Vaccines Product Portfolio
-
Table Adimmune Company Details
-
Table Adimmune Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adimmune Human Vaccines Main Business and Markets Served
-
Table Adimmune Human Vaccines Product Portfolio
-
Table NuoCheng Bio Company Details
-
Table NuoCheng Bio Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table NuoCheng Bio Human Vaccines Main Business and Markets Served
-
Table NuoCheng Bio Human Vaccines Product Portfolio
-
Table Walvax Biotechnology Company Details
-
Table Walvax Biotechnology Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Walvax Biotechnology Human Vaccines Main Business and Markets Served
-
Table Walvax Biotechnology Human Vaccines Product Portfolio
-
Table Zhifei Company Details
-
Table Zhifei Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zhifei Human Vaccines Main Business and Markets Served
-
Table Zhifei Human Vaccines Product Portfolio
-
Table Changsheng Life Company Details
-
Table Changsheng Life Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Changsheng Life Human Vaccines Main Business and Markets Served
-
Table Changsheng Life Human Vaccines Product Portfolio
-
Table Changchun Baike Company Details
-
Table Changchun Baike Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Changchun Baike Human Vaccines Main Business and Markets Served
-
Table Changchun Baike Human Vaccines Product Portfolio
-
Table Hualan Bio Company Details
-
Table Hualan Bio Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hualan Bio Human Vaccines Main Business and Markets Served
-
Table Hualan Bio Human Vaccines Product Portfolio
-
Table SANOFI Company Details
-
Table SANOFI Human Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table SANOFI Human Vaccines Main Business and Markets Served
-
Table SANOFI Human Vaccines Product Portfolio
-
Figure Global Varicella Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Polio Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis A Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rabies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BCG Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adults Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Children Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Human Vaccines Consumption Forecast by Country (2022-2028)
-
Table North America Human Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Germany Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Human Vaccines Consumption Forecast by Country (2022-2028)
-
Figure China Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Human Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Brazil Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Human Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Human Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Human Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Australia Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Human Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
